ESR1 and breast cancer: A 2013 study conducted a correlation of ELK1 expression and localization to key BC markers like ER, Cyclin D1, and Ki67, and concluded that ELK1 had a positive correlation with the first two highlighting its significance as a potential marker or prognosis predictor [58].